快速液体输注对血红蛋白浓度的影响:系统评价与Meta分析
该系统评价与Meta分析纳入65项研究、共2794例成人,评估快速液体输注(<120 min晶体和/或胶体)前后血红蛋白浓度变化。63项研究可合并分析,快速液体输注后血红蛋白平均显著下降1.33 g/dL(95%CI -1.45至-1.12;p<0.001;I²=96.88);非急性病患者平均下降1.56 g/dL,急性病患者平均下降0.84 g/dL,脓毒症患者下降幅度小于其他急性病患者。液体无反应者氧输送显著下降且血红蛋白显著下降。作者认为该效应可能限制液体挑战对氧输送及组织氧合的正向作用。
要点
- 快速液体输注后血红蛋白平均下降1.33 g/dL(95%CI -1.45至-1.12;p<0.001;I²=96.88)。
- 非急性病患者血红蛋白平均下降1.56 g/dL(95%CI -1.69至-1.42;p<0.001;I²=96.71),急性病患者平均下降0.84 g/dL(95%CI -1.03至-0.64;p=0.033;I²=92.91)。
- 脓毒症患者血红蛋白下降幅度小于其他急性病患者。
- 液体无反应者氧输送显著下降,且血红蛋白显著下降。
- 作者认为该稀释效应可能限制液体挑战对氧输送及组织氧合的正向作用。
适用人群与场景
- 成人患者,研究按非急性病与急性病(外科/创伤、脓毒症、循环性休克或严重低血容量、混合情况)分组。
- 排除纳入出血患者、使用输血或体外循环操作的研究。
诊断标准与关键阈值
- 快速液体输注定义为在小于120分钟内给予晶体液和/或胶体液的团注液体。
研究设计与关键结果
- 系统评价与Meta分析,纳入65项研究(非急性病患者40项,急性病患者25项),共2794例参与者。
- 随机对照试验偏倚风险评为「低」,非随机对照试验评为「低至中等」。
- 63项研究可合并分析,快速液体输注后血红蛋白平均显著下降1.33 g/dL(95%CI -1.45至-1.12;p<0.001;I²=96.88)。
- 非急性病患者血红蛋白平均下降1.56 g/dL(95%CI -1.69至-1.42;p<0.001;I²=96.71);急性病患者平均下降0.84 g/dL(95%CI -1.03至-0.64;p=0.033;I²=92.91)。
- 脓毒症患者血红蛋白下降幅度小于其他急性病患者。
- 液体无反应者氧输送显著下降,同时血红蛋白显著下降。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,方案注册于PROSPERO(CRD42020165146)。
- 检索PubMed、Cochrane数据库和Embase自建库至2022年2月15日。
- 采用随机效应模型、Meta回归和亚组分析;使用Cochrane偏倚风险评估工具评估偏倚风险,使用I²统计量评估异质性。
- 作者结论:快速液体输注后血红蛋白一致下降,证据确定性为中等。
- 局限:异质性高(总体I²=96.88;非急性病I²=96.71;急性病I²=92.91)。
对床旁实践的改变
- 在快速液体输注(<120分钟晶体和/或胶体)的成人中,需预期血红蛋白平均下降约1.33 g/dL,非急性病患者下降约1.56 g/dL,急性病患者下降约0.84 g/dL。
- 脓毒症患者血红蛋白下降幅度小于其他急性病患者。
- 液体无反应者氧输送显著下降且血红蛋白显著下降,液体挑战对氧输送的正向效应可能被稀释效应限制。
- 作者认为快速液体输注后的血红蛋白下降可能限制液体挑战对氧输送及组织氧合的正向作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rapid fluid administration may decrease hemoglobin concentration (Hb) by a diluting effect, which could limit the increase in oxygen delivery (DO2) expected with a positive response to fluid challenge in critically ill patients. Our aim was to quantify the decrease in Hb after rapid fluid administration.
METHODS: Our protocol was registered in PROSPERO (CRD42020165146). We searched PubMed, the Cochrane Database, and Embase from inception until February 15, 2022. We selected studies that reported Hb before and after rapid fluid administration (bolus fluid given over less than 120 min) with crystalloids and/or colloids in adults. Exclusion criteria were studies that included bleeding patients, or used transfusions or extracorporeal circulation procedures. Studies were divided according to whether they involved non-acutely ill or acutely ill (surgical/trauma, sepsis, circulatory shock or severe hypovolemia, and mixed conditions) subjects. The mean Hb difference and, where reported, the DO2 difference before and after fluid administration were extracted. Meta-analyses were conducted to assess differences in Hb before and after rapid fluid administration in all subjects and across subgroups. Random-effect models, meta-regressions and subgroup analyses were performed for meta-analyses. Risk of bias was assessed using the Cochrane Risk of Bias Assessment Tool. Inconsistency among trial results was assessed using the I2 statistic.
RESULTS: Sixty-five studies met our inclusion criteria (40 in non-acutely ill and 25 in acutely ill subjects), with a total of 2794 participants. Risk of bias was assessed as "low" for randomized controlled trials (RCTs) and 'low to moderate' for non-RCTs. Across 63 studies suitable for meta-analysis, the Hb decreased significantly by a mean of 1.33 g/dL [95% CI - 1.45 to - 1.12; p < 0.001; I2 = 96.88] after fluid administration: in non-acutely ill subjects, the mean decrease was 1.56 g/dL [95% CI - 1.69 to - 1.42 ; p < 0.001; I2 = 96.71] and in acutely ill patients 0.84 g/dL [95% CI - 1.03 to - 0.64; p = 0.033; I2 = 92.91]. The decrease in Hb was less marked in patients with sepsis than in other acutely ill patients. The DO2 decreased significantly in fluid non-responders with a significant decrease in Hb.
CONCLUSIONS: Hb decreased consistently after rapid fluid administration with moderate certainty of evidence. This effect may limit the positive effects of fluid challenges on DO2 and thus on tissue oxygenation.
参考来源
- Quispe-Cornejo AA, Alves da Cunha AL, Njimi H, et al. Effects of rapid fluid infusion on hemoglobin concentration: a systematic review and meta-analysis. Crit Care. 2022. PMID: 36274172. doi:10.1186/s13054-022-04191-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。